FDA Inspection 1080056 — Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Xianju Junye Pharmaceutical Co., Ltd. on Jan 11, 2019 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 11, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)